SOURCE: Equity Spotlight

May 01, 2013 08:30 ET Announces Trade Alerts on: ONCS, WSGP, DCTH, and TTHI

NOTE TO EDITORS: The Following Is An Investment Opinion Issued By Equity Spotlight

NEW YORK, NY--(Marketwired - May 1, 2013) - focuses on identifying the hottest small cap companies in today's market. We are the #1 source for the best penny stocks alerts.

Alerts for today are issued on the following stocks: ONCS, WSGP, DCTH, and TTHI

OncoSec Medical Incorporated (OTCQB: ONCS) - shares saw an unusual break out on Tuesday closing up nearly 10% on roughly 3.6 million shares traded. The Company designs, develops, and commercializes novel cancer therapeutic products in the United States.

You can read more about ONCS here:

Western Graphite Inc. (OTCQB: WSGP) - shares closed up 13% yesterday on nearly 1.7 million shares traded. The company announced on Monday that it will be participating in the upcoming Turkey Mining Show in Istanbul scheduled for June 18-20, 2013.

You can read more about WSGP here:

Delcath Systems, Inc. (NASDAQ: DCTH) - closed down 40% on Tuesday and hit a new 52-week low of $0.7701 after the FDA said that the Company's medical device-chemotherapy system will not be approved until Delcath conducts a new clinical trial.

You can read more about DCTH here:

Transition Therapeutics Inc. (NASDAQ: TTHI) - hit a new 52-week high of $3.84 yesterday after announcing positive results of a five-week proof of concept clinical study of TT-401 in type 2 diabetic and obese non-diabetic subjects.

You can read more about TTHI here:

For more promising small-cap companies that look poised for upside growth, visit:

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. No representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

Contact Information